Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 12Lymphoid 12Sarcoma 7Dermatologic 7Thoracic 6Myeloid 5Gastrointestinal 5Gynecologic 4Tumor-Agnostic 3Plasma cell 3Head & Neck 3Other neoplasm 2Genitourinary 2Classical hematology 2Other solid neoplasm 1CNS 1Breast 1

Conditions

Head and Neck Neoplasms 14Squamous Cell Carcinoma of Head and Neck 9Uterine Cervical Neoplasms 7Ovarian Neoplasms 7Anus Neoplasms 7Nasopharyngeal Carcinoma 6Melanoma 6Vaginal Neoplasms 5Stomach Neoplasms 5Penile Neoplasms 5Oropharyngeal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Neoplasm Metastasis 4Esophageal Neoplasms 4Vulvar Neoplasms 3Recurrence 3Pancreatic Neoplasms 3Neoplasms 3Colorectal Neoplasms 3Carcinoma, Transitional Cell 3Carcinoma, Squamous Cell 3Carcinoma, Renal Cell 3Carcinoma, Merkel Cell 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma, Synovial 2Lung Neoplasms 2Hodgkin Disease 2Endometrial Neoplasms 2

Interventions

pembrolizumab 33Cetuximab 16Cisplatin 10Radiotherapy 8Paclitaxel 8Docetaxel 8atezolizumab 7Fluorouracil 7cemiplimab 6Drug Therapy 6budigalimab 5Gemcitabine 5Cyclophosphamide 5Blood Specimen Collection 5trametinib 4Pemetrexed 4Nivolumab 4Magnetic Resonance Spectroscopy 4Bleomycin 4Bevacizumab 4palbociclib 3fludarabine 3durvalumab 3dabrafenib 3avelumab 3Trastuzumab 3Oxaliplatin 3Interleukin-2 3Indocyanine Green 3Immunotherapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasms × fludarabine × Head & Neck × Clear all
NCT06096038 2026-02-20

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

UNC Lineberger Comprehensive Cancer Center

Phase 1/2 Recruiting
33 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms, Recurrence

NCT02876510 2025-02-04

ACTolog

Immatics US, Inc.

Phase 1 Completed
38 enrolled
GastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT04596033 2022-07-15

TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy

Genocea Biosciences, Inc.

Phase 1 Terminated
49 enrolled
DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma, Neoplasms, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡